Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
Dow
AstraZeneca
Colorcon

Last Updated: May 26, 2022

OXAYDO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Oxaydo, and what generic alternatives are available?

Oxaydo is a drug marketed by Zyla and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.

This drug has thirteen patent family members in six countries.

The generic ingredient in OXAYDO is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.

Drug patent expirations by year for OXAYDO
Drug Prices for OXAYDO

See drug prices for OXAYDO

Recent Clinical Trials for OXAYDO

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stanford UniversityPhase 3

See all OXAYDO clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for OXAYDO
Paragraph IV (Patent) Challenges for OXAYDO
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
OXAYDO Tablets oxycodone hydrochloride 5 mg and 7.5 mg 202080 1 2012-02-07

US Patents and Regulatory Information for OXAYDO

OXAYDO is protected by six US patents.

Patents protecting OXAYDO

Methods and compositions for deterring abuse of opioid containing dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Methods and compositions for deterring abuse of opioid containing dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Extended release opioid abuse deterrent compositions and methods of making same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Compositions for deterring abuse of opioid containing dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Abuse deterrent compositions and methods of making same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-001 Jun 17, 2011 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-002 Jun 17, 2011 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-001 Jun 17, 2011 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-002 Jun 17, 2011 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-002 Jun 17, 2011 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-001 Jun 17, 2011 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-001 Jun 17, 2011 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for OXAYDO

See the table below for patents covering OXAYDO around the world.

Country Patent Number Title Estimated Expiration
Israel 175863 PHARMACEUTICAL COMPOSITIONS FOR DETERRING ABUSE OF OPIOID CONTAINING DOSAGE FORMS See Plans and Pricing
World Intellectual Property Organization (WIPO) 2005053587 See Plans and Pricing
Spain 2637338 See Plans and Pricing
European Patent Office 2420225 Procédés et compositions permettant d'empêcher l'abus d'opioïde contenant des formes de dosage (Methods and compositions for deterring abuse of opioid containing dosage forms) See Plans and Pricing
European Patent Office 1694260 PROCEDES ET COMPOSITIONS POUR EMPECHER UN ABUS DE FORMES PHARMACEUTIQUES CONTENANT DES OPIOIDES (METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF OPIOID CONTAINING DOSAGE FORMS) See Plans and Pricing
Australia 2013206525 Methods and compositions for deterring abuse of opioid containing dosage forms See Plans and Pricing
Israel 221018 שיטות ותכשירים להרתיע שימוש לרע בצורות מינון המכילות אופיאואיד (Methods and compositions for deterring abuse of opioid containing dosage forms) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for OXAYDO

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1685839 92292 Luxembourg See Plans and Pricing PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Boehringer Ingelheim
Moodys
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.